BiotechTube
Home/KaliVir Immunotherapeutics/Schond Greenway
SG

Schond Greenway

Chief Financial Officer

KaliVir Immunotherapeutics

Therapeutic Areas

Oncology

KaliVir Immunotherapeutics Pipeline

DrugIndicationPhase
VET3-TGIAdvanced Solid TumorsPhase 1

Leadership Team at KaliVir Immunotherapeutics

JM
James M. Burke, M.D.
Chief Medical Officer
UF
Ursula Fritsch, PharmD
Chief Regulatory Officer
AP
Adina Pelusio
Chief Development Officer
PY
Paul Youm
Vice President, Corporate Development and Alliance Management
View full KaliVir Immunotherapeutics profile